Skip to main content
NeuroThera Labs Inc. logo

NeuroThera Labs Inc. — Investor Relations & Filings

Ticker · NTLX ISIN · CA64136J1012 LEI · 529900GPL3C0DVADMS32 TSXV Manufacturing
Filings indexed 145 across all filing types
Latest filing 2021-12-21 Regulatory Filings
Country CA Canada
Listing TSXV NTLX

About NeuroThera Labs Inc.

https://www.neurothera.com/

NeuroThera Labs Inc. is a clinical-stage company specializing in the development of therapeutics and advanced technologies for central nervous system (CNS) disorders and brain health. The company operates through two primary development streams. First, it is a leader in photobiomodulation (PBM) technology, developing drug-free, non-invasive devices for neurotherapy, targeting conditions such as Major Depressive Disorder (MDD), Alzheimer’s Disease, and Traumatic Brain Injury (TBI). Second, NeuroThera maintains a pharmaceutical pipeline focused on novel drug candidates, including programs based on THC and proprietary opioid/non-opioid compounds designed to enhance pain relief and treat CNS disorders. This dual approach leverages both advanced medical devices and clinical-stage drug candidates to address prevalent neurological conditions.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of Miza III Ventures Inc. regarding the interim financial report for the period ended October 31, 2021. It is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate. The text contains no actual financial data or analysis but is an attestation about the interim filing's accuracy and fair presentation. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is short (2998 characters), and it is clearly a certification, not the report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-12-21 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis' (MD&A) for the nine months ended October 31, 2021, prepared by Miza III Ventures Inc. It contains detailed financial data, operational results, liquidity and capital resources, risks and uncertainties, share capital information, and other management commentary. The document includes substantive financial data and analysis for a period shorter than a full fiscal year (nine months), which fits the definition of an Interim / Quarterly Report (IR). It is not a brief announcement or a certification letter, nor is it a full annual report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2022
2021-12-21 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED OCTOBER 31, 2021' and contains detailed unaudited financial statements including statements of financial position, loss and comprehensive loss, shareholders' equity, cash flows, and notes to the financial statements. It explicitly states it is an interim report covering a period shorter than a full fiscal year (nine months). The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The presence of substantive financial data and analysis confirms it is an interim/quarterly report rather than a regulatory filing or announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2021
2021-12-20 English
News release - English.pdf
Regulatory Filings
2021-11-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-09-29 English
Interim MD&A - English.pdf
Regulatory Filings
2021-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.